D-Glutamate

D-Glutamate

SCHEMBL1065173

NC(CCC(=O)O)C(=O)O.O=P(O)(O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.82
GRM6 O15303 2/20 0.82
GRM7 Q14831 2/20 0.82
GRM4 Q14833 2/20 0.82
GRM3 Q14832 2/20 0.82
GRIN2D O15399 1/20 0.82
GRIN3B O60391 1/20 0.82
GSR P00390 1/20 0.82
CYP1A2 P05177 1/20 0.82
GRIK1 P39086 1/20 0.82
GRM5 P41594 1/20 0.82
GRIA1 P42261 1/20 0.82
GRIA2 P42262 1/20 0.82
GRIA3 P42263 1/20 0.82
SLC1A3 P43003 1/20 0.82
SLC1A2 P43004 1/20 0.82
SLC1A1 P43005 1/20 0.82
GRIA4 P48058 1/20 0.82
GRIN1 Q05586 1/20 0.82
GRIN2A Q12879 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL49767 1.00 GRM8 (0.82) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL27732867 0.98 GRM8 (0.78) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL19717585 0.98 GRM8 (0.78) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL28656083 0.98 GRM8 (0.78) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL28078987 0.91 GRM8 (0.75) GRM8GRM6GRM7GRM4GRM3
Glutamic Acid SCHEMBL5704264 0.91 GRM8 (1.00) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL1330824 0.91 GRM8 (1.00) GRM8GRM6GRM7GRM4GRM3
Glutamic Acid SCHEMBL1554237 0.91 GRM8 (1.00) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL17127348 0.91 GRM8 (1.00) GRM8GRM6GRM7GRM4GRM3
D-Glutamate SCHEMBL1330484 0.91 GRM8 (1.00) GRM8GRM6GRM7GRM4GRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111662360-B Turtle small peptide and preparation method and application thereof 华中农业大学 2021-08-31 CN claimed
US-20190284282-A1 STABLE PHARMACEUTICAL COMPOSITION DR. REDDY'S LABORATORIES LIMITED (IN) 2019-09-19 US claimed
EP-3402470-A1 STABLE PHARMACEUTICAL COMPOSITION Dr. Reddy's Laboratories Limited (IN) 2018-11-21 EP claimed
WO-2017122121-A1 STABLE PHARMACEUTICAL COMPOSITION DR. REDDY'S LABORATORIES LIMITED (IN) 2017-07-20 WO claimed
CN-103282486-B There is the microorganism of the ornithine throughput of improvement and use the method for this microorganisms producing ornithine CJ CHEILJEDANG CORP. (KR) 2016-02-17 CN claimed
CN-103282486-A Microbes with an improved ability to produce ornithine and method for producing ornithine using same CJ CHEILJEDANG CORP 2013-09-04 CN claimed
US-20130137639-A1 STABLE MIA/CD-RAP FORMULATION SCIL TECHNOLOGY GMBH (DE) 2013-05-30 US claimed
EP-2563809-A2 STABLE AQUEOUS MIA/CD-RAP FORMULATIONS Scil Technology GmbH (DE) 2013-03-06 EP claimed
CN-102869679-A Stable MIA/CD-RAP formulation SCIL TECHNOLOGY GMBH 2013-01-09 CN claimed
WO-2011134979-A9 STABLE AQUEOUS MIA/CD-RAP FORMULATIONS SCIL TECHNOLOGY GMBH (DE) 2012-08-16 WO claimed
WO-2011134979-A2 STABLE MIA/CD-RAP FORMULATION SCIL TECHNOLOGY GMBH (DE) 2011-11-03 WO claimed
WO-2010085731-A2 PRODUCTION OF 1,4 BUTANEDIOL IN A MICROORGANISM MICROBIA, INC. (US) 2010-07-29 WO claimed
CN-120731949-A Amino acid ionic liquid and application thereof 农业农村部环境保护科研监测所 2025-10-03 CN disclosed
CN-117321069-A Vaccine composition based on attenuated reovirus and use thereof 百洛克株式会社 2023-12-29 CN disclosed
US-20230058072-A1 COSMETIC COMPOSITION CREASEARCH BV (BE) 2023-02-23 US disclosed
EP-4096621-A1 COSMETIC COMPOSITION CreaSearch BV (BE) 2022-12-07 EP disclosed
CN-1333361-A Novel polypeptide--human L-3-phosphoserine phosphatase 10.01 and polynucleotide for encoding said polypeptide BODE GENE DEV CO LTD SHANGHAI (CN) 2002-01-30 CN disclosed
CN-1199402-A Method for production of magnesium pyridoxal-5'-phosphate glutamate and intermediate products obtained thereby STEIGERWALD ARZNEIMITTELWERK (DE) 1998-11-18 CN disclosed
US-5441735-A Containing Erwinia CENTRAL GLASS CO., LTD. (JP) 1995-08-15 US disclosed
US-4504515-A Process for preparing low-fat meat products and in particular sausages with high protein content HOHENESTER HERMANN (DE) 1985-03-12 US disclosed